文献速递临床试验与 GCP

丙泊酚、环泊酚或瑞马唑仑麻醉下胃肠镜期间梦境:平行设计双盲单中心试验的研究方案

Dreaming during gastrointestinal endoscopy under propofol, ciprofol, or remimazolam anesthesia: study protocol for a parallel-design double-blind, single-center trial.
PubMed 文献 · Trials · 2024-01-02

本研究为前瞻性、平行设计、双盲、单中心临床试验,拟纳入360例择期无痛胃镜、肠镜或胃肠镜受检者,分别接受丙泊酚、环泊酚或瑞马唑仑诱导麻醉,于恢复室采用改良Brice问卷访谈,主要结局为梦境发生率,次要结局包括梦境类型、睡眠质量改善、患者评价、麻醉不足发生率及术中知晓,安全结局为检查期间低血压和缺氧发生率及恢复期不良事件。

要点

  • 拟纳入360例择期无痛胃镜、肠镜或胃肠镜受检者,随机接受丙泊酚、环泊酚或瑞马唑仑麻醉。
  • 主要结局为梦境发生率,于恢复室采用改良Brice问卷访谈评估。
  • 次要结局包括梦境类型、睡眠质量改善、患者评价、麻醉不足发生率及术中知晓。

核心结论

  • 本研究可能观察到不同的梦境发生率和多样的梦境类型,进而可能对麻醉操作产生不同评价。
  • 基于将获得的结果,麻醉医师可为拟接受无痛诊疗的患者制定更好的用药方案。

研究设计与样本

  • 前瞻性、平行设计、双盲、单中心临床试验。
  • 拟纳入360例择期无痛胃镜、肠镜或胃肠镜受检者。
  • 符合条件者分别接受丙泊酚、环泊酚或瑞马唑仑诱导麻醉以完成检查。
  • 于恢复室进行改良Brice问卷访谈。
  • 试验于2023年5月18日在中国临床试验注册中心注册,注册号ChiCTR2300071565。

主要发现

  • 主要结局为梦境发生率。
  • 次要结局包括梦境类型、睡眠质量改善、患者评价、麻醉不足发生率及术中知晓。
  • 安全结局为检查期间低血压和缺氧发生率及恢复期不良事件。

临床怎么用

  • 作者认为,基于将获得的结果,麻醉医师可为拟接受无痛诊疗的患者制定更好的用药方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dreaming sometimes occurs during sedation. It has been reported that factors such as different anesthetics, depth of anesthesia, age, sex, and preoperative psychological state may affect dreams. Ciprofol and remimazolam are novel choices for painless endoscopy. Herein, we aimed to investigate dreaming during gastrointestinal endoscopy under propofol, ciprofol, and remimazolam anesthesia respectively. METHODS: This is a prospective, parallel-design double-blind, single-center clinical trial. Three hundred and sixty subjects undergoing elective painless gastroscopy, colonoscopy, or gastroenteroscopy will be enrolled. Eligible subjects will undergo propofol-, ciprofol-, or remimazolam-induced anesthesia to finish the examination. Interviews about the modified Brice questionnaire will be conducted in the recovery room. Incidence of dreaming is set as the primary outcome. Secondary outcomes include type of dreams, improvement of sleep quality, evaluation of patients, incidence of insufficient anesthesia, and intraoperative awareness. Safety outcomes are the incidences of hypotension and hypoxia during examination and adverse events during recovery. DISCUSSION: This study may observe different incidences of dreaming and diverse types of dreams, which might lead to different evaluations to the anesthesia procedure. Based on the coming results, anesthesiologists can make a better medication plan for patients who are going to undergo painless diagnosis and treatment. TRIAL REGISTRATION: This trial was registered at the Chinese Clinical Trial Registry on May 18, 2023 (registration number ChiCTR2300071565).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xia LQ, Zhou R, Deng R, et al. Dreaming during gastrointestinal endoscopy under propofol, ciprofol, or remimazolam anesthesia: study protocol for a parallel-design double-blind, single-center trial. Trials. 2024. PMID: 38167210. doi:10.1186/s13063-023-07873-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。